CQCIT Clinical Trial Imaging

The CQCIT provides state-of-the-art molecular imaging with PET/CT and SPECT/CT to enable high-quality research and assist clinicians in diagnosing disease and monitoring therapy. These molecular imaging technologies provide “precision medicine” for each patient while obtaining biologic information non-invasively. 

The CQCIT performs a range of research PET/CT scans for patients participating in clinical trials at Huntsman Cancer Institute and the University of Utah. These include studies using FDA-approved PET radiopharmaceuticals as well as investigational radiopharmaceuticals under IND. All clinical trials must be previously approved by the University of Utah Institutional Review Board. The CQCIT also performs select clinical PET/CT scans in support of the Huntsman Cancer Institute Hospital and Sugar House Health Center of the University of Utah.